Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on June 11, 2021. The filing addresses the reconvening of the Company's 2021 Annual Meeting of Stockholders, which was previously adjourned on May 13, 2021.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance events rather than financial performance data.
Material Changes
The primary event reported is the failure to achieve a quorum at the reconvened Annual Meeting on June 11, 2021. Consequently, the meeting was adjourned again. No changes were made to the proposals to be voted on by stockholders.
Outlook and Management Commentary
- Meeting Reschedule: The Annual Meeting is reconvened for July 9, 2021, at 8:30 a.m. Pacific Time / 11:30 a.m. Eastern Time.
- Location: The meeting will be held at the Company's offices at 200 Pine Street, Suite 400, San Francisco, CA 94104.
- Record Date: The record date remains April 12, 2021.
- Shareholder Action: Stockholders who have already voted do not need to take further action unless they wish to change their vote.
- Reference Materials: Investors are directed to the definitive proxy statement on Schedule 14A filed on April 13, 2021.
Key Facts for Investor Verification
- Verify the quorum requirements and the number of shares present at the July 9, 2021 meeting.
- Confirm the status of the proposals originally scheduled for the May 13, 2021 meeting.
- Review the definitive proxy statement (Schedule 14A) for details on the specific matters to be voted upon.
- Monitor future filings for the outcome of the July 9, 2021 Annual Meeting.